Glenvastatin

Glenvastatin

SCHEMBL1040745

CC(C)c1nc(-c2ccccc2)cc(-c2ccc(F)cc2)c1C=CC1CC(O)CC(=O)O1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 12/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glenvastatin SCHEMBL29557142 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL1040744 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL9872411 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL49508 1.00 HMGCR (1.00) HMGCR
SCHEMBL9022892 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL1660022 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL10024037 1.00 HMGCR (1.00) HMGCR
SCHEMBL9527887 0.96 HMGCR (1.00) HMGCR
SCHEMBL9022328 0.94 HMGCR (0.89) HMGCR
SCHEMBL9023237 0.92 HMGCR (0.85) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9259872-B2 Multiparticulates EURO-CELTIQUE S.A. (LU) 2016-02-16 US claimed
US-9259872-B2 Multiparticulates EURO-CELTIQUE S.A. (LU) 2016-02-16 US disclosed
EP-2269582-A2 Multiparticulates of preferably an opioid, and method of manufacturing using extrusion EURO-CELTIQUE S.A. (LU) 2011-01-05 EP disclosed
US-20080260815-A1 Extruded with water permeability modifier and platicizer that also acts as lubricant; pH independent release profile; opioid controlled release EURO-CELTIQUE S.A. (LU) 2008-10-23 US disclosed